-
Immune cells fighting blood cancer visualized for the first time
worldpharmanews
April 10, 2019
When cancer escapes the immune system, our defenses are rendered powerless and are unable to fight against the disease...
-
NICE recommends BMS’ Opdivo-Yervoy combination for RCC
pharmaceutical-technology
April 09, 2019
Bristol-Myers Squibb (BMS) has announced that the National Institute of Health and Care Excellence (NICE) has recommends Opdivo (nivolumab) and...
-
Novel First-In-Class FLIP Inhibitors for the Treatment of Cancer
b3cnewswire
April 09, 2019
Novel First-In-Class FLIP Inhibitors for the Treatment of Cancer
-
XenTech SAS Partners with Gustave Roussy for Cancer
contractpharma
April 03, 2019
For the development of a collection of tumor explant models from patients who developed acquired resistance to targeted therapies following initial responses.
-
Triphase Accelerator Initiates Phase I Trial of TRPH-222
contractpharma
April 02, 2019
Next-Gen Antibody-Drug Conjugate developed using Catalent’s SMARTag ADC Technology
-
New glioblastoma cancer vaccine shows promise in phase 1b clinical trial
europeanpharmaceuticalreview
April 02, 2019
A brain-cancer vaccine more than 20 years in the making suspends cancer growth in patients enrolled in early-stage trial…
-
Researchers target metastasis in fight against cancer
worldpharmanews
March 29, 2019
An experimental combination drug therapy attacking the DNA integrity of cancer cells is showing promise for a possible new cancer therapy in the future.
-
GT Biopharma Restructures Management Team
contractpharma
March 27, 2019
Cataldo named chief executive officer, Weldon appointed as chief financial officer.
-
Pivotal phase III trial launched in recurrent ovarian cancer
europeanpharmaceuticalreview
March 26, 2019
INNOVATE-3 will test the efficacy of Tumor Treating Fields combined with paclitaxel in patients with recurrent, platinum-resistant ovarian cancer…
-
FDA Warns Homeopathic Company About Illegal Product Claims
drugs
March 20, 2019
Nutra Pharma Corp. has been warned about illegal marketing of unapproved homeopathic products with claims that they can treat addiction and chronic pain from serious conditions such as cancer, diabetes, shingles, and fibromyalgia, the U.S. Food and Drug A